中文名 | 贝托斯汀 |
---|---|
英文名 | bepotastine |
中文别名 |
(+)-(S)-4-[4-[1-(4-氯苯基)-1-(2-吡啶)甲氧基]哌啶-1-基]丁酸
4-[4-[(4-氯苯基)吡啶-2-基甲氧基]哌啶-1-基]丁酸 |
英文别名 |
(+)-(S)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butyric acid monobenzenesulfonate
4-[(S)-(4-chlorophenyl)-2-pyridinylMethoxy] 4-{4-[(S)-(4-Chlorophenyl)(2-pyridinyl)methoxy]-1-piperidinyl}butanoic acid (+)-(S)-4-{4[(4-chlorphenyl)(2-pyridil)methoxy]piperidino}butyric acid monobenzenesulfonate 1-Piperidinebutanoic acid, 4-[(S)-(4-chlorophenyl)-2-pyridinylmethoxy]- 1-Piperidinebutanoic acid,4-[(S)-(4-chlorophenyl)-2-pyridinylmethoxy] 4-[4-[(4-Chlorophenyl)pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid (+)-(S)-4-[4-[1-(4-chlorophenyl)-1-(2-pyridyl)methoxy]piperidin-1-yl]butyric acid [14C]-Bepotastine besilate Bepotastine 4-(4-[(1S)(4-CHLOROPHENYL)-2-PYRIDYLMETHOXY]PIPERIDYL)BUTANOIC ACID betotastine besilate 4-(4-((S)-(4-Chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic Acid (+)-4-(((S)-p-Chloro-2-pyridylbenzyl)oxy)-1-piperidinebutyric Acid betotastine Bepreve 4-{4-[(S)-(4-Chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic acid |
描述 | Bepotastine 是一种具有口服活性的第二代组胺 H1 受体拮抗剂。Bepotastine 可用于过敏性鼻炎和荨麻疹/瘙痒症的研究。 |
---|---|
相关类别 | |
靶点 |
Histamine H1 receptor[1] |
参考文献 |
密度 | 1.3±0.1 g/cm3 |
---|---|
沸点 | 546.8±50.0 °C at 760 mmHg |
熔点 | 56-58 °C |
分子式 | C21H25ClN2O3 |
分子量 | 388.888 |
闪点 | 284.5±30.1 °C |
精确质量 | 388.155365 |
PSA | 62.66000 |
LogP | 3.67 |
外观性状 | 固体 |
蒸汽压 | 0.0±1.5 mmHg at 25°C |
折射率 | 1.605 |
储存条件 | 2-8°C, 惰性气体 |
危害码 (欧洲) | Xn |
---|
125602-71-3 ~64% 125602-71-3 |
文献:Ha, Tae Hee; Suh, Kwee-Hyun; Lee, Gwan Sun Bulletin of the Korean Chemical Society, 2013 , vol. 34, # 2 p. 549 - 552 |
125602-71-3 ~68% 125602-71-3 |
文献:Hanmi Pharm. Co., Ltd. Patent: US2010/137367 A1, 2010 ; Location in patent: Page/Page column 3 ; |
~% 125602-71-3 |
文献:US2014/46068 A1, ; |
~% 125602-71-3 |
文献:US2014/46068 A1, ; |
~% 125602-71-3 |
文献:US2014/46068 A1, ; |